Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Ly3295668 erbumine's trials
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
LY3295668 Erbumine
Ongoing
Active not recruiting
Phase 1
Open NCT04106219 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
